← Back to Search

Behavioral Intervention

Ads about response efficacy for quitting smoking for Smoking

N/A
Waitlist Available
Led By Marissa G Hall, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
This national trial is not open to enrollment from the general public. Participation is restricted to individuals who meet the following inclusion
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after exposure to the ads, assessed during one-time online 15-minute survey.
Awards & highlights

Summary

The main purpose of this trial is to identify effective quit smoking ads for people who smoke menthol cigarettes. Investigators will conduct an online randomized trial with a nationally representative sample of \~1,400 US adults (ages 21+) who smoke menthol cigarettes.

Who is the study for?
This trial is for US adults aged 21 or older who currently smoke menthol cigarettes. The goal is to find out which ads are most effective at encouraging them to quit smoking.
What is being tested?
The study is testing the effectiveness of different types of advertisements designed to help people quit smoking. Participants will be randomly assigned to view either control ads or intervention ads.
What are the potential side effects?
Since this trial involves viewing advertisements, there are no direct medical side effects associated with participation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after exposure to the ads, assessed during one-time online 15-minute survey.
This trial's timeline: 3 weeks for screening, Varies for treatment, and after exposure to the ads, assessed during one-time online 15-minute survey. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Perceived message effectiveness for motivation
Secondary study objectives
Intentions to quit smoking
Perceived message effectiveness for response efficacy
Perceived message effectiveness for self-efficacy
+2 more

Trial Design

5Treatment groups
Experimental Treatment
Group I: Ads about self-efficacy for quitting smokingExperimental Treatment1 Intervention
Participants will view ads designed to increase self-efficacy to quit smoking.
Group II: Ads about response efficacy for quitting smokingExperimental Treatment1 Intervention
Participants will view ads designed to increase response efficacy for quitting cigarettes.
Group III: Ads about readingExperimental Treatment1 Intervention
Participants will view non-smoking related ads on the benefits of reading.
Group IV: Ads about passwordsExperimental Treatment1 Intervention
Participants will view non-smoking related ads on passwords.
Group V: Ads about motivation to quit smokingExperimental Treatment1 Intervention
Participants will view ads designed to increase motivation to quit smoking.

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,543 Previous Clinical Trials
4,239,715 Total Patients Enrolled
5 Trials studying Smoking
2,325 Patients Enrolled for Smoking
Food and Drug Administration (FDA)FED
178 Previous Clinical Trials
1,542,712 Total Patients Enrolled
2 Trials studying Smoking
72 Patients Enrolled for Smoking
National Institute on Drug Abuse (NIDA)NIH
2,532 Previous Clinical Trials
3,245,248 Total Patients Enrolled
68 Trials studying Smoking
22,671 Patients Enrolled for Smoking
~0 spots leftby Oct 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top